Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study

BACKGROUND: Previous studies have shown mortality benefits with corticosteroids in Coronavirus disease-19 (COVID-19). However, there is inconsistency regarding the use of methylprednisolone over dexamethasone in COVID-19, and this has not been extensively evaluated in patients with a history of asth...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Sulaiman, Khalid, Aljuhani, Ohoud, Korayem, Ghazwa B., Altebainawi, Ali, Alharbi, Reham, Assadoon, Maha, Vishwakarma, Ramesh, Ismail, Nadia H., Alshehri, Asma A., Al Mutairi, Faisal E., AlFaifi, Mashael, Alharthi, Abdullah F., Alenazi, Abeer A., Alalawi, Mai, Al Zumai, Omar, Al Haji, Hussain, Al Dughaish, Sarah T., Alawaji, Abdulrahman S., Alhaidal, Haifa A., Al Ghamdi, Ghassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463591/
https://www.ncbi.nlm.nih.gov/pubmed/37641042
http://dx.doi.org/10.1186/s12890-023-02603-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463591/
https://www.ncbi.nlm.nih.gov/pubmed/37641042
http://dx.doi.org/10.1186/s12890-023-02603-4

Ejemplares similares